Ralf Voshtina, DO
Neurology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Voshtina’s office at (650) 723-4000 to ask if they take your plan before you enroll.
State licence records
1 licence
- Illinois 125078295Temporary Medical Permit · since 2024 · expires 2025-06-21Specialty on the licence: NeurologyExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
$15,314
Pharmacies billed $15,314 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 169) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
157 generic and 12 brand-name prescriptions · $15,314 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levetiracetam | 11 | $1,759 | $160 |
| Memantine | 27 | $381 | $14 |
| Atorvastatin | 24 | $277 | $12 |
| Amlodipine Besylate | 15 | $85 | $6 |
Year by year
| 2024 | 169 | 42 | 0% (0) | 7% | $15,314 |
| 2023 | 114 | 35 | None | 10% | $8,418 |
| 2022 | 45 | 16 | 0% (0) | 0% | $1,047 |
| 2021 | 22 | None | 0% (0) | None | $726 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Eliquis | 11 | $6,605 | $600 |
| Gabapentin | 16 | $253 | $16 |
| Atorvastatin | 17 | $237 | $14 |
| Ropinirole | 14 | $181 | $13 |
| Amitriptyline | 13 | $155 | $12 |
2022: 1 drug
| Gabapentin | 12 | $232 | $19 |
Money from drug and device companies
$96 in 2025
| 2025 | 2 | 2 | None | $96 |
| 2023 | 1 | 2 | None | $251 |
| 2022 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Percept PC Brainsense | $51 | 1 payment
|
| TG Therapeutics | Briumvi | $45 | 1 payment
|
See all 2 published payments
| Medtronic | Meals · 2025-07-16 | Percept PC Brainsense | $51 |
| TG Therapeutics | Meals · 2025-03-25 | Briumvi | $45 |
See earlier years (2023, 2022)
2023: $251
| Alexion Pharmaceuticals | Soliris | $251 | 2 payments
|
2022: $125
| E.R. Squibb & Sons L.L.C. | Zeposia | $125 | 1 payment
|
Professional record
- NPI
- 1558948281
- Licence
- IL 125.078295Illinois 125078295: Expired
- Trained
- Midwestern University, Chicago College of Osteopathic Med, 2021
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084N0600X (2084N0600X); Neurology (2084N0400X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2021-03-27
- NPI last updated
- 2026-07-02
- NPI record certified
- 2026-07-02
This is when the NPI record was last certified, not a medical board exam.